
1 

(1) This Order may be cited as the National Health Service (Pharmaceutical Services) and (Misuse of Drugs) (Electronic Communications) Order 2001 and shall come into force on 11th September 2001:
(2) This Order extends to England only.
2 

(1) The National Health Service (Pharmaceutical Services) Regulations 1992 are amended as follows.
(2) In regulation 2(1) (interpretation)—
(a) in the appropriate alphabetical position, insert—“
 “the 2000 Act” means the Electronic Communications Act 2000;”,“
 “electronic communication” has the same meaning as in section 15 of the 2000 Act;”,“
 “electronic signature” has the same meaning as in section 7 of the 2000 Act;”;
(b) in the definition of “prescription form”, after “means” insert “, subject to regulation 2A,”.
(3) After regulation 2, insert—“
2A 

(1) In these Regulations, where the conditions set out in paragraph (2) are met—
(a) the term “prescription form” includes data that—
(i) are created in an electronic form and signed with an electronic signature and are transmitted as an electronic communication;
(ii) are created in an electronic form and signed with an electronic signature, where both the data and the signature are entered on the prescription form in a non-legible manner;
(iii) are created in writing and signed with an electronic signature which is entered on the prescription form in a non-legible manner; or
(iv) are created in an electronic form and entered on the prescription form in a non-legible manner, and signed in ink;
(b) any reference to presentation of a prescription form includes transmission of data created in an electronic form as an electronic communication.
(2) The conditions are—
(a) that the prescription is an order for a drug or appliance and is issued by a doctor in connection with the provision of general medical services or personal medical services;
(b) that the order is not for an oxygen concentrator; and
(c) that the Secretary of State is satisfied that—
(i) the use of electronic means in order to create, sign and transmit prescriptions (or whichever of those purposes is applicable) is appropriate for the purposes of a pilot scheme on the use of electronic prescribing in relation to the doctor and, where relevant, the chemist and the premises at which the prescription is dispensed; and
(ii) the particular electronic means used by the doctor and, where relevant, the chemist concerned are suitable for the purposes of such a pilot scheme.”.
3 
In regulation 20(8) (arrangements for provision of pharmaceutical services by doctors), after “issuing”, insert “a prescription form by electronic means or by issuing”.
4 

(1) Part II of Schedule 2 (terms of service for chemists) is amended as follows.
(2) In sub-paragraph (1C) of paragraph 3—
(a) in paragraph (a), omit the words “on the prescription form”; and
(b) in paragraph (b), for “the prescription form”, substitute “the form on which the declaration is made”.
(3) In sub-paragraph (2)(a) of paragraph 5, for “who presents a prescription”, substitute “named on a prescription form”.
5 
In Part III of Schedule 2 (terms of service for doctors who provide pharmaceutical services), in paragraph 11B—
(a) in paragraph (a), omit the words “on the prescription form”; and
(b) in paragraph (b), for “the prescription form”, substitute “the form on which the declaration is made”.
6 

(1) The Misuse of Drugs Regulations 1985 are amended as follows.
(2) In regulation 16(2), for “paragraph (3)” substitute “paragraphs (2A) and (3)”.
(3) After regulation 16(2), insert—“
(2A) A person supplying temazepam on prescription in accordance with a prescription form of a kind specified in regulation 2A(1)(a)(i) of the National Health Service (Pharmaceutical Services) Regulations 1992 shall, at the time of the supply, enter on the form by electronic means the date on which the drug is supplied.”
Signed by authority of the Secretary of State for Health
Hazel Blears
Parliamentary Under-Secretary of State,
Department of Health
20th August 2001